1. Skip to content

Category: Treatment News

  • Orphan Drug New Immunotherapy Treatment

    Another pharmaceutical company is dedicating resources to help find an effective treatment for mesothelioma. Its efforts have led to an Orphan Drug Designation from the U.S. Food and Drug Administration, and comes on the heels of CRS-207 and tremelimumab, two other drugs developed to make a difference for mesothelioma patients, receiving the same designation from …

    Label: Treatment News

    Posted on Thursday, Sep 17, 2015